Groupe Pierre Fabre

Veterinary imaging has long relied on "human-med adaptations," resulting in slow, noisy diagnostics. HawkCell is redefining the standard. We’ve built the first high-impact AI exclusively for animal health, using animal-specific data to solve unique clinical challenges. We turn imaging departments from bottlenecks into high-margin growth drivers.

Our core tech optimizes existing infrastructure:

• HawkAI: Slashes MRI scan times by 50%, doubling throughput and reducing anesthesia risks.
• HawkCT: Enables ultra-low-dose scans (50% less radiation/iodine) while extending hardware life.

As a cloud-based, OEM-agnostic solution, we standardize diagnostic quality across global fleets without hardware overhauls.

Following a 2024 Series A, HawkCell is scaling across Europe, North America, and APAC. Based in Lyon with more than 10 nationalities, we are building the technical infrastructure for the future of animal health.

Waiv, a spin-out of Owkin, exists to catalyze precision medicine with clinical-grade, AI-powered tests that accelerate biomarker discovery and detection, outcome prediction, and treatment-response assessment across oncology.

Built on over seven years of validated medical-AI innovation and one of Europe’s largest multi-institutional data networks, we deliver precise, accurate, and fast analyses that support treatment decisions.

Through our industry-leading tech and AI stack, and clinically validated, already-deployed AI tests, such as RlapsRisk BC, we unlock morphological insights and future-proof both the clinical diagnostic workflow and pharmaceutical R&D pipelines, to ultimately bring scalable precision medicine to patients worldwide. 

www.wearewaiv.com

UNVEIL is a deep tech instrumentation start-up launched in 2024 as a spin-off from the Institut d’Optique Graduate School – Université Paris Saclay.

We aim to eliminate the technological barriers facing biologists and researchers today. As the biotech community develops treatments for cancer and autoimmune diseases using bioparticles, the ability to see and control interactions at the single-particle level is game-changing.

Our instruments leverage the most advanced nanophotonics techniques to provide the essential tools needed to solve these challenges.

Racine Carrée (R²) est un centre médical haut de gamme spécialisé dans la greffe capillaire FUE, la médecine esthétique du cheveu et les traitements régénératifs

(facteurs de croissance, mésothérapie, cellules souches, exosomes, trichopigmentation).
Située à Levallois-Perret, Racine Carrée dispose d’un espace de 900 m² avec 15 salles de greffe dernière génération et un salon de coiffure intégré , alliant excellence médicale, technologie et expérience patient sur mesure.

Notre mission : accompagner chaque patient dans la redécouverte de sa confiance. De la première consultation à la repousse finale, nos médecins spécialisés maîtrisent les techniques les plus avancées pour des résultats naturels, quels que soient le type de cheveux ou le profil.

Avec un suivi personnalisé (1, 6 et 12 mois), des protocoles transparents et une approche 100 % orientée bien-être, Racine Carrée s’impose comme la référence française de la greffe capillaire et de la santé du cheveu.

Over 500 life-saving drugs used every day were born from the microbial world. And yet, 97% of this natural pharmacopeia remains hidden, waiting to be discovered. At Generare, we hold a conviction: these unexplored molecules hold the answers to diseases that still resist modern medicine.

We are building the only industrial-scale platform capable of uncovering this microbial treasure trove on a global scale. Our mission? To transform millions of years of nature's trial-and-error into concrete therapeutic solutions for human and animal health, as well as the agriculture of tomorrow.

In 2025, our patented technology combining synthetic and computational biology has already led to the identification of over 200 new molecules derived from microbes, four times faster than the rest of the world combined. But beyond the technology, what makes us strong is the team behind it : scientists, engineers, and technicians from diverse backgrounds, united by the same scientific rigor and collaborative spirit. At Generare, everyone actively shapes our trajectory, in an environment where rigor and humility go hand in hand, and where people matter as much as results.

This is only the beginning.

At Takara Bio, our mission is to contribute to the development of revolutionary biotechnologies for the improvement of human health. Most known for our industry-leading enzymes and NGS solutions, we also offer a wide array of life science products and services in areas such as stem cell and gene therapies, and mRNA vaccine development.

Takara Bio Europe is a subsidiary of the Japanese company Takara Bio Inc., the company also has locations in the US and throughout Asia.